Effect of cytochrome b5 content on the activity of polymorphic CYP1A2, 2B6, and 2E1 in human liver microsomes

PLoS ONE

Volumn 10, Issue 6, 2015, Pages

  Zhang, Haifeng ^a   Gao, Na ^a   Liu, Tingting ^a   Fang, Yan ^a   Qi, Bing ^a   Wen, Qiang ^a   Zhou, Jun ^a   Jia, Linjing ^a   Qiao, Hailing ^a  

^a ZHENGZHOU UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ADENINE; CYTOCHROME B5; CYTOCHROME P450 1A2; CYTOCHROME P450 2B6; CYTOCHROME P450 2E1; CYTOSINE; GUANINE; THYMINE; CYP1A2 PROTEIN, HUMAN; MESSENGER RNA;

ADULT; AGED; ARTICLE; CHINESE; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; GENOTYPE; HUMAN; HUMAN CELL; HUMAN TISSUE; INTRINSIC CLEARANCE; LIVER MICROSOME; MALE; PROTEIN CONTENT; PROTEIN EXPRESSION; SEX DIFFERENCE; SINGLE NUCLEOTIDE POLYMORPHISM; SMOKING; CHINA; COHORT ANALYSIS; GENETICS; KINETICS; METABOLISM; MIDDLE AGED;

ADULT; AGED; CHINA; COHORT STUDIES; CYTOCHROME P-450 CYP1A2; CYTOCHROME P-450 CYP2B6; CYTOCHROME P-450 CYP2E1; CYTOCHROMES B5; FEMALE; GENOTYPE; HUMANS; KINETICS; MALE; MICROSOMES, LIVER; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; RNA, MESSENGER; SEX FACTORS; SMOKING;

EID: 84934977903     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0128547     Document Type: Article

References (40)

1. Ozols J. Structure of cytochrome b5 and its topology in the microsomal membrane. Biochim Biophys Acta. 1989; 997: 121-130. PMID: 2752049
2. Giordano SJ, Steggles AW. The human liver and reticulocyte cytochrome b5 mRNAs are products from a single gene. Biochem Biophys Res Commun. 1991; 178: 38-44. PMID: 1712589
3. Sacco JC, Trepanier LA. Cytochrome b5 and NADH cytochrome b5 reductase: genotype-phenotype correlations for hydroxylamine reduction. Pharmacogenet Genomics. 2010; 20: 26-37. PMID: 19997042 doi: 10.1097/FPC.0b013e3283343296
4. Henderson CJ, McLaughlin LA, Finn RD, Ronseaux S, Kapelyukh Y, Wolf CR. A role for cytochrome b5 in the In vivo disposition of anticancer and cytochrome P450 probe drugs in mice. Drug Metab Dispos. 2014; 42: 70-77. PMID: 24115751 doi: 10.1124/dmd.113.055277
5. Peng HM, Auchus RJ. The action of cytochrome b(5) on CYP2E1 and CYP2C19 activities requires anionic residues D58 and D65. Biochemistry. 2013; 52: 210-220. PMID: 23193974 doi: 10.1021/bi301384n
6. Vergeres G, Waskell L. Cytochrome b5, its functions, structure and membrane topology. Biochimie. 1995; 77: 604-620. PMID: 8589071
7. Schenkman JB, Jansson I. The many roles of cytochrome b5. Pharmacol Ther. 2003; 97: 139-152. PMID: 12559387
8. Storbeck KH, Swart AC, Goosen P, Swart P. Cytochrome b5: novel roles in steroidogenesis. Mol Cell Endocrinol. 2013; 371: 87-99. PMID: 23228600 doi: 10.1016/j.mce.2012.11.020
9. Kurian JR, Bajad SU, Miller JL, Chin NA, Trepanier LA. NADH cytochrome b5 reductase and cytochrome b5 catalyze the microsomal reduction of xenobiotic hydroxylamines and amidoximes in humans. J Pharmacol Exp Ther. 2004; 311: 1171-1178. PMID: 15302896
10. Takahashi K, Oda Y, Toyoda Y, Fukami T, Yokoi T, Nakajima M. Regulation of cytochrome b5 expression by miR-223 in human liver: effects on cytochrome P450 activities. Pharm Res. 2014; 31: 780-794. PMID: 24078287
11. Gan L, von Moltke LL, Trepanier LA, Harmatz JS, Greenblatt DJ, Court MH. Role of NADPH-cytochrome P450 reductase and cytochrome-b5/NADH-b5 reductase in variability of CYP3A activity in human liver microsomes. Drug Metab Dispos. 2009; 37: 90-96. PMID: 18838505 doi: 10.1124/dmd.108.023424
12. Nebert DW, Dalton TP. The role of cytochrome P450 enzymes in endogenous signalling pathways and environmental carcinogenesis. Nat Rev Cancer. 2006; 6: 947-960. PMID: 17128211
13. Zanger UM, Schwab M. Cytochrome P450 enzymes in drug metabolism: regulation of gene expression, enzyme activities, and impact of genetic variation. Pharmacol Ther. 2013; 138: 103-141. PMID: 23333322 doi: 10.1016/j.pharmthera.2012.12.007
14. Palma BB, Silva ESM, Urban P, Rueff J, Kranendonk M. Functional characterization of eight human CYP1A2 variants: the role of cytochrome b5. Pharmacogenet Genomics. 2013; 23: 41-52. PMID: 23295917 doi: 10.1097/FPC.0b013e32835c2ddf
15. Meyer UA. Pharmacogenetics - five decades of therapeutic lessons from genetic diversity. Nat Rev Genet. 2004; 5: 669-676. PMID: 15372089
16. Zanger UM, Turpeinen M, Klein K, Schwab M. Functional pharmacogenetics/genomics of human cytochromes P450 involved in drug biotransformation. Anal Bioanal Chem. 2008; 392: 1093-1108. PMID: 18695978 doi: 10.1007/s00216-008-2291-6
17. Xie HJ, Yasar U, Lundgren S, Griskevicius L, Terelius Y, Hassan M, Rane A. Role of polymorphic human CYP2B6 in cyclophosphamide bioactivation. Pharmacogenomics J. 2003; 3: 53-61. PMID: 12629583
18. Trafalis DT, Panteli ES, Grivas A, Tsigris C, Karamanakos PN. CYP2E1 and risk of chemically mediated cancers. Expert Opin Drug Metab Toxicol. 2010; 6: 307-319. PMID: 20073996 doi: 10.1517/17425250903540238
19. Hildebrandt A, Estabrook RW. Evidence for the participation of cytochrome b 5 in hepatic microsomal mixed-function oxidation reactions. Arch Biochem Biophys. 1971; 143: 66-79. PMID: 4397839
20. Zhao C, Gao Q, Roberts AG, Shaffer SA, Doneanu CE, Xue S, et al. Cross-linking mass spectrometry and mutagenesis confirm the functional importance of surface interactions between CYP3A4 and holo/apo cytochrome b(5). Biochemistry. 2012; 51: 9488-9500. PMID: 23150942 doi: 10.1021/bi301069r
21. Peng HM, Liu J, Forsberg SE, Tran HT, Anderson SM, Auchus RJ. Catalytically Relevant Electrostatic Interactions of Cytochrome P450c17 (CYP17A1) and Cytochrome b5. J Biol Chem. 2014; 289: 33838-33849. PMID: 25315771 doi: 10.1074/jbc.M114.608919
22. Shimada T, Misono KS, Guengerich FP. Human liver microsomal cytochrome P-450 mephenytoin 4-hydroxylase, a prototype of genetic polymorphism in oxidative drug metabolism. Purification and characterization of two similar forms involved in the reaction. J Biol Chem. 1986; 261: 909-921. PMID: 3079764
23. Yamazaki H, Nakano M, Gillam EM, Bell LC, Guengerich FP, Shimada T. Requirements for cytochrome b5 in the oxidation of 7-ethoxycoumarin, chlorzoxazone, aniline, and N-nitrosodimethylamine by recombinant cytochrome P450 2E1 and by human liver microsomes. Biochem Pharmacol. 1996; 52: 301-309. PMID: 8694855
24. Yamazaki H, Nakano M, Imai Y, Ueng YF, Guengerich FP, Shimada T. Roles of cytochrome b5 in the oxidation of testosterone and nifedipine by recombinant cytochrome P450 3A4 and by human liver microsomes. Arch Biochem Biophys. 1996; 325: 174-182. PMID: 8561495
25. Yamazaki H, Nakamura M, Komatsu T, Ohyama K, Hatanaka N, Asahi S, et al. Roles of NADPH-P450 reductase and apo- and holo-cytochrome b5 on xenobiotic oxidations catalyzed by 12 recombinant human cytochrome P450s expressed in membranes of Escherichia coli. Protein Expr Purif. 2002; 24: 329-337. PMID: 11922748
26. Yamazaki H, Johnson WW, Ueng YF, Shimada T, Guengerich FP. Lack of electron transfer from cytochrome b5 in stimulation of catalytic activities of cytochrome P450 3A4. Characterization of a reconstituted cytochrome P450 3A4/NADPH-cytochrome P450 reductase system and studies with apocytochrome b5. J Biol Chem. 1996; 271: 27438-27444. PMID: 8910324
27. Yamazaki H, Gillam EM, Dong MS, Johnson WW, Guengerich FP, Shimada T. Reconstitution of recombinant cytochrome P450 2C10(2C9) and comparison with cytochrome P450 3A4 and other forms: effects of cytochrome P450-P450 and cytochrome P450-b5 interactions. Arch Biochem Biophys. 1997; 342: 329-337. PMID: 9186495
28. Finn RD, McLaughlin LA, Ronseaux S, Rosewell I, Houston JB, Henderson CJ, Wolf CR. Defining the in Vivo Role for cytochrome b5 in cytochrome P450 function through the conditional hepatic deletion of microsomal cytochrome b5. J Biol Chem. 2008; 283: 31385-31393. PMID: 18805792 doi: 10.1074/jbc.M803496200
29. Im SC, Waskell L. The interaction of microsomal cytochrome P450 2B4 with its redox partners, cytochrome P450 reductase and cytochrome b(5). Arch Biochem Biophys. 2011; 507: 144-153. PMID: 21055385 doi: 10.1016/j.abb.2010.10.023
30. Laki S, Kalapos-Kovacs B, Antal I, Klebovich I. [Importance of drug interactions with smoking in modern drug research]. Acta Pharm Hung. 2013; 83: 107-120. PMID: 24575657
31. Kaspera R, Naraharisetti SB, Evangelista EA, Marciante KD, Psaty BM, Totah RA. Drug metabolism by CYP2C8.3 is determined by substrate dependent interactions with cytochrome P450 reductase and cytochrome b5. Biochem Pharmacol. 2011; 82: 681-691. PMID: 21726541 doi: 10.1016/j.bcp.2011.06.027
32. Jerabek P, Florian J, Stiborova M, Martinek V. Flexible docking-based molecular dynamics/steered molecular dynamics calculations of protein-protein contacts in a complex of cytochrome P450 1A2 with cytochrome b5. Biochemistry. 2014; 53: 6695-6705. PMID: 25313797 doi: 10.1021/bi500814t
33. Djordjevic N, Ghotbi R, Jankovic S, Aklillu E. Induction of CYP1A2 by heavy coffee consumption is associated with the CYP1A2 -163C>A polymorphism. Eur J Clin Pharmacol. 2010; 66: 697-703. PMID: 20390257 doi: 10.1007/s00228-010-0823-4
34. Soyama A, Saito Y, Hanioka N, Maekawa K, Komamura K, Kamakura S, et al. Single nucleotide polymorphisms and haplotypes of CYP1A2 in a Japanese population. Drug Metab Pharmacokinet. 2005; 20: 24-33. PMID: 15770072
35. Martiny VY, Miteva MA. Advances in molecular modeling of human cytochrome P450 polymorphism. J Mol Biol. 2013; 425: 3978-3992. PMID: 23856621 doi: 10.1016/j.jmb.2013.07.010
36. Shimada T, Mernaugh RL, Guengerich FP. Interactions of mammalian cytochrome P450, NADPH-cytochrome P450 reductase, and cytochrome b(5) enzymes. Arch Biochem Biophys. 2005; 435: 207-216. PMID: 15680923
37. Kandel SE, Lampe JN. Role of protein-protein interactions in cytochrome P450-mediated drug metabolism and toxicity. Chem Res Toxicol. 2014; 27: 1474-1486. PMID: 25133307 doi: 10.1021/tx500203s
38. Backes WL, Kelley RW. Organization of multiple cytochrome P450s with NADPH-cytochrome P450 reductase in membranes. Pharmacol Ther. 2003; 98: 221-233. PMID: 12725870
39. Patten CJ, Ning SM, Lu AY, Yang CS. Acetone-inducible cytochrome P-450: purification, catalytic activity, and interaction with cytochrome b5. Arch Biochem Biophys. 1986; 251: 629-638. PMID: 3800390
40. Snyder R, Chepiga T, Yang CS, Thomas H, Platt K, Oesch F. Benzene metabolism by reconstituted cytochromes P450 2B1 and 2E1 and its modulation by cytochrome b5, microsomal epoxide hydrolase, and glutathione transferases: evidence for an important role of microsomal epoxide hydrolase in the formation of hydroquinone. Toxicol Appl Pharmacol. 1993; 122: 172-181. PMID: 8211999